Healthcare Services

Cognitive Diagnostics Market: Trends, Drivers, and Opportunities

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cognitive Diagnostics Market During 2026–2030?

The cognitive diagnostics market size has experienced significant expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. The historical development can be linked to the rising prevalence of neurodegenerative disorders, heightened awareness of cognitive health, advancements in diagnostic imaging capabilities, increased adoption of standardized cognitive tests, and the expansion of neurology specialty clinics.

The cognitive diagnostics market is poised for substantial growth over the next few years. It is projected to expand to $17.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.7%. The expansion throughout the forecast period is fueled by escalating investments in digital diagnostics, an increasing need for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing incorporation of AI into clinical decision support, and a heightened emphasis on personalized cognitive care. Prominent trends anticipated in this period include the rising application of AI-based cognitive assessment instruments, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the widespread availability of remote cognitive testing solutions, and a reinforced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

What Leading Drivers Are Supporting The Cognitive Diagnostics Market Expansion?

The increasing occurrence of neurological conditions is anticipated to fuel expansion within the cognitive diagnostics market moving forward. These conditions, which impact the brain, spinal cord, and nervous system, hinder their proper functioning and manifest in symptoms like cognitive decline, motor impairment, and sensory issues. The surge in neurological disorders is largely attributable to a higher incidence of age-associated illnesses, including Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, alongside exposure to environmental toxins, stress, poor dietary habits, and inactive lifestyles, also contribute to their growing prevalence. Cognitive diagnostics play a crucial role in neurological diseases by evaluating, identifying, and tracking cognitive deficits, thereby assisting in the prompt diagnosis and management of conditions such as Alzheimer’s and Parkinson’s disease. For instance, in May 2024, a report from the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is a key factor driving the growth of the cognitive diagnostics market.

What Are The Key Segment Divisions In The Cognitive Diagnostics Market Segment Structure?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Emerging Trends Are Seen In The Cognitive Diagnostics Market?

Key companies operating in the cognitive diagnostics market are prioritizing real-time insights into cognitive health, propelled by technological advancements in diagnostic tools such as neuropsychological testing platforms, to heighten the accuracy, efficiency, and comprehensiveness of cognitive assessments. Neuropsychological testing platforms are specialized digital instruments created to evaluate cognitive functions through standardized tests, covering memory, attention, and problem-solving abilities. For instance, in April 2024, BrainCheck Inc., a US-based digital health company advancing cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its sophisticated tools for cognitive screening, assessment, and care planning. The platform, featuring Assess, Screen, and Plan, offers clinicians a contemporary solution to streamline cognitive health management with mobile, digital technology, ensuring precision and user-friendliness. This innovation aims to improve the efficiency and quality of care for patients and providers by delivering nuanced, evidence-based recommendations and thorough care planning.

Which Organizations Are Engaged In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Get The Full Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Region Dominates The Cognitive Diagnostics Market By Market Share?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cognitive Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795